Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon
- PMID: 7625535
Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon
Abstract
Mass treatments with ivermectin have been undertaken each year since 1987 in an area hyperendemic for onchocerciasis in northern Cameroon. The impact of these successive treatments on the incidence of infection in humans was evaluated by comparing the prevalence of skin microfilariae (PMF) and the mean microfilarial skin densities (MFD) observed in 1987 and 1992 in 5-7-year-old children who had never taken the drug but who were members of the treated communities. In 1992, the PMF and the MFD in children in this age group who never received ivermectin were reduced by 55% and 77%, respectively, in comparison with the values observed in 1987, before the first treatment round. These results reflect a pronounced reduction in the intensity of the transmission of Onchocerca volvulus in the treatment zone. The influence of the ivermectin treatment coverage in the human population, as well as the vectorial capacity and the dispersal of the vector blackflies, on the transmission of onchocerciasis is discussed.
Similar articles
-
Impact of four years of large-scale ivermectin treatment with low therapeutic coverage on the transmission of Onchocerca volvulus in the Mbam valley focus, central Cameroon.Trans R Soc Trop Med Hyg. 2004 Sep;98(9):520-8. doi: 10.1016/j.trstmh.2003.11.010. Trans R Soc Trop Med Hyg. 2004. PMID: 15251400
-
After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.Trop Med Int Health. 2008 Sep;13(9):1196-203. doi: 10.1111/j.1365-3156.2008.02126.x. Epub 2008 Jul 8. Trop Med Int Health. 2008. PMID: 18631308
-
Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.J Vector Borne Dis. 2008 Mar;45(1):29-37. J Vector Borne Dis. 2008. PMID: 18399314
-
Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.Acta Trop. 2011 Sep;120 Suppl 1:S100-8. doi: 10.1016/j.actatropica.2010.08.009. Epub 2010 Aug 27. Acta Trop. 2011. PMID: 20801094 Review.
-
[Molecular approaches to the control of onchocerciasis in Mexico].Rev Latinoam Microbiol. 2005 Jul-Dec;47(3-4):112-29. Rev Latinoam Microbiol. 2005. PMID: 17061536 Review. Spanish.
Cited by
-
Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.Parasit Vectors. 2015 Oct 9;8:515. doi: 10.1186/s13071-015-1122-9. Parasit Vectors. 2015. PMID: 26452723 Free PMC article. Clinical Trial.
-
Factors associated with coverage of praziquantel for schistosomiasis control in the community-direct intervention (CDI) approach in Mali (West Africa).Infect Dis Poverty. 2013 Jun 10;2(1):11. doi: 10.1186/2049-9957-2-11. Infect Dis Poverty. 2013. PMID: 23849481 Free PMC article.
-
Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3180. doi: 10.1371/journal.pntd.0003180. eCollection 2014 Sep. PLoS Negl Trop Dis. 2014. PMID: 25232954 Free PMC article.
-
Contribution and performance of female Community-Directed Distributors in the treatment of onchocerciasis with Ivermectin in Sub-Saharan Africa: a systematic review.Pan Afr Med J. 2015 Feb 27;20:188. doi: 10.11604/pamj.2015.20.188.3337. eCollection 2015. Pan Afr Med J. 2015. PMID: 26430485 Free PMC article.
-
Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin.Filaria J. 2006 Feb 5;5:1. doi: 10.1186/1475-2883-5-1. Filaria J. 2006. PMID: 16457735 Free PMC article.